BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions

Not Applicable

Completed

Conditions: Atherosclerosis
Coronary Artery Disease

Interventions: Device: Percutaneous coronary intervention (NG PROMUS)

First Posted Date: 2012-10-10

Last Posted Date: 2014-04-15

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 100

Registration Number: NCT01703000

Locations: 🇳🇿
Middlemore Hospital, Otahuhu, New Zealand
🇳🇿
Christchurch, Christchurch, New Zealand
🇳🇿
Ascot Angiography, Auckland, New Zealand

and more 6 locations

WallFlex Esophageal Fully Covered (FC) Benign Anastomotic Stricture

Not Applicable

Completed

Conditions: Refractory Anastomotic Esophageal Strictures

Interventions: Device: WallFlex Esophageal RX Fully Covered Stent
Device: Esophageal Bougie Dilator Per Investigator preference

First Posted Date: 2012-10-03

Last Posted Date: 2021-06-28

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 18

Registration Number: NCT01699542

Locations: 🇳🇱
Erasmus Medical Center, Rotterdam, CE, Netherlands
🇳🇱
Academisch Medisch Centrum, Amsterdam, Netherlands
🇸🇪
Karolinska Universitets Sjukhuset, Stockholm, Sweden

and more 1 locations

Safety and Performance Study of the INGEVITY Lead

Not Applicable

Completed

Conditions: Bradycardia
Sinus Node Dysfunction

Interventions: Device: INGEVITY lead

First Posted Date: 2012-09-20

Last Posted Date: 2020-03-10

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1060

Registration Number: NCT01688843

Locations: 🇪🇸
Hospital Clinico Y Provincial, Barcelona, Spain
🇺🇸
Wellstar Research Institute, Marietta, Georgia, United States
🇺🇸
Staten Island University Hospital, Staten Island, New York, United States

and more 75 locations

Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation

Not Applicable

Completed

Conditions: Paroxysmal Atrial Fibrillation (PAF)

Interventions: Device: Blazer Open-Irrigated Ablation Catheter (Boston Scientific)
Device: FDA Approved Open-Irrigated Ablation Catheter

First Posted Date: 2012-09-18

Last Posted Date: 2018-11-21

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 398

Registration Number: NCT01687166

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Caritas St. Elizabeth's Medical Center, Boston, Massachusetts, United States
🇺🇸
Sequoia Hospital, Redwood City, California, United States

and more 35 locations

Post-Approval Study of PROMUS Element™ in China

Completed

Conditions: Coronary Artery Disease

First Posted Date: 2012-09-03

Last Posted Date: 2022-02-24

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 2016

Registration Number: NCT01677585

Locations: 🇨🇳
Second Affliated Hosptial Zhejiang University College of Medicine, Hangzhou, China

Embozene Microspheres for Uterine Fibroid Embolization (UFE)

Not Applicable

Terminated

Conditions: Uterine Fibroids

Interventions: Device: Embosphere®
Device: Embozene® Microspheres

First Posted Date: 2012-08-29

Last Posted Date: 2016-03-11

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 4

Registration Number: NCT01675011

Locations: 🇺🇸
Albany Medical Center, Albany, New York, United States
🇺🇸
North Shore LIJ Medical Center, New Hyde Park, New York, United States

Clinical Outcomes Study Using a New Implantable Neurostimulation System for Chronic Intractable Pain

Not Applicable

Completed

Conditions: Chronic Pain

Interventions: Device: Neurostimulation device implantation

First Posted Date: 2012-08-15

Last Posted Date: 2020-11-19

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 40

Registration Number: NCT01665040

Locations: 🇦🇺
Metro Spinal Clinic, Caulfield, Australia
🇦🇺
Hunter Clinical Research, Melbourne, Australia
🇪🇸
Clinica Universitaria de Navarra, Madrid, Spain

and more 4 locations

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Phase 3

Completed

Conditions: Coronary Artery Disease

Interventions: Device: PROMUS Element Plus
Device: SYNERGY

First Posted Date: 2012-08-15

Last Posted Date: 2019-01-30

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1684

Registration Number: NCT01665053

Locations: 🇺🇸
Rex Hospital, Raleigh, North Carolina, United States
🇺🇸
Maine Medical Center, Portland, Maine, United States
🇺🇸
MedStar Union Memorial Hospital, Baltimore, Maryland, United States

and more 123 locations

Randomized Study of Failed SCS Trials Comparing Outcomes Using the Observational Mechanical Gateway (OMG) Connector

Not Applicable

Completed

Conditions: Chronic Pain

Interventions: Device: BSC approved SCS Trial Therapy w/ OMG
Device: Non Boston Scientific SCS Trial Therapy

First Posted Date: 2012-07-18

Last Posted Date: 2020-11-13

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 27

Registration Number: NCT01643213

Locations: 🇺🇸
Coastal Orthopedics and Sports Medicine of Southwest Florida, PA, Bradenton, Florida, United States
🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
🇺🇸
West Virginia University Hospitals, Morgantown, West Virginia, United States

and more 10 locations

Electroanatomical Mapping of Patients Undergoing Catheter Ablation Procedures Using Rhythmia Mapping System and Catheter

Not Applicable

Completed

Conditions: Cardiac Arrhythmias

Interventions: Device: Rhythmia Mapping System and the Rhythmia Mapping Catheter

First Posted Date: 2012-07-17

Last Posted Date: 2021-06-04

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 7

Registration Number: NCT01642537

Locations: 🇨🇦
London Health Sciences Centre, London, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy